On the other hand, there are four variables in both models with a decreasing effect on the hazard ratio if their value is increased (intake of drugs to treat benign prostatic hypertrophy, treated dyslipidemia, IGF-1 and female sex). This evidence concerns the gene IGF1 and metabolic syndrome.